News

Clearmind Medicine's International Patent for Ibogaine Therapy

Clearmind Medicine's International Patent for Ibogaine Therapy

Clearmind Medicine Announces New Patent Application for Ibogaine Therapy

Clearmind Medicine Inc. (NASDAQ: CMND), a prominent clinical-stage biotech company recognized for creating innovative therapeutics derived from psychedelics, has exciting news. They've filed an international patent application under the Patent Cooperation Treaty (PCT) for a groundbreaking combination therapy utilizing Ibogaine and N-Acylethanolamines.

The Promise of Ibogaine in Addiction Treatment

Ibogaine, a potent compound extracted from the Tabernanthe iboga plant, has shown remarkable promise in clinical trials targeting various substance use disorders, including opioid use disorder (OUD) and cocaine use disorder (CUD). As ongoing research continues to affirm its effectiveness, Ibogaine is emerging as a potential anti-addiction agent, opening doors for new treatment avenues that could greatly benefit those struggling with addiction.

Partnership with SciSparc Ltd.

This significant development stems from a fruitful collaboration between Clearmind and SciSparc Ltd. (NASDAQ: SPRC), a pharmaceutical company specializing in central nervous system disorders. Together, they are working to create innovative therapies that blend psychedelic compounds with the advantageous qualities of N-Acylethanolamines, such as Palmitoylethanolamide (PEA).

Cutting-Edge Solutions for Mental Health

Dr. Adi Zuloff-Shani, CEO of Clearmind, highlighted the company’s commitment to pioneering breakthroughs in the psychedelic therapy space. He remarked, “This patent publication demonstrates Clearmind's determination to build a comprehensive patent portfolio filled with groundbreaking technologies. Our aim is to provide safe and effective treatments for mental health challenges that continue to be overlooked. Although Ibogaine treatments have generally shown safety under medical supervision, concerns persist regarding adverse effects from raw iboga plant material. By combining Ibogaine with PEA, we hope to enhance safety and efficacy, thereby improving the therapeutic outcomes for our patients.”

About Clearmind Medicine Inc.

Clearmind Medicine is at the forefront of the psychedelic pharmaceutical field, focusing on researching and developing unique compounds derived from psychedelics to address pressing health issues, including alcohol use disorder. With a clear vision for the future, Clearmind aims to transform these psychedelic compounds into regulated medicines that can bring meaningful benefits to large populations.

Broadening the Intellectual Property Portfolio

The company boasts an impressive portfolio featuring nineteen patent families and a total of thirty granted patents. Clearmind is dedicated to pursuing further patent protections for its innovations and is well-positioned to acquire additional intellectual property as opportunities present themselves.

About SciSparc Ltd.

SciSparc Ltd. is well-known for its commitment to developing advanced cannabinoid pharmaceuticals. The company spearheads initiatives related to drug programs designed to treat various conditions, including Tourette Syndrome and Alzheimer's, underscoring its mission to tackle a wide range of health challenges through scientific advancements.

Contact Information for Investor Relations

For more details about Clearmind Medicine, interested parties can visit the company’s official website or reach out directly: Investors: invest@clearmindmedicine.com | Telephone: (604) 260-1566. For general inquiries, please contact Info@Clearmindmedicine.com.

Frequently Asked Questions

What does Clearmind Medicine aim to achieve?

Clearmind Medicine specializes in discovering and developing psychedelic-derived therapeutics designed to address serious mental health issues.

What is Ibogaine and its role in therapy?

Ibogaine is a compound obtained from the iboga plant, and it's being explored for its potential in treating substance use disorders through novel therapies.

Which company partnered with Clearmind in this new therapy development?

Clearmind has partnered with SciSparc Ltd. to innovate combination therapies that bolster the effects of psychedelics in mental health treatment.

What benefits might Clearmind’s new therapy offer?

This therapy could enhance safety and effectiveness for patients facing addiction challenges, significantly improving treatment outcomes.

How can I keep track of Clearmind Medicine's progress?

You can stay updated by visiting Clearmind's official website or subscribing to their investor relations updates.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Papa John's Faces Investor Lawsuit: Class Action Looms

Updated Category News Views 0

Papa John's in Hot Water Again? Look, just when you think the pizza game is all dough and cheesy goodness, along comes a legal scuffle to toss our assumptions. Bronstein, Gewirtz & Grossman, LLC has slapped a class action lawsuit against Papa John's International, Inc. (NASDAQ: PZZA), claiming the company and some of its higher-ups haven't been playing fair with the...

Continue Reading
Michigan Roof Inspections: Seasonal Insights That Count

Updated Category News Views 2

Weather's Wrath and the Michigan Roof Here's the deal: Michigan doesn't mess around when it comes to weather. We're talking harsh winters with piles of snow, followed by muggy summers that toss storms like they're confetti. Keeping that roof in top shape isn't just some luxury; it’s a downright necessity. Gut-punch reality? Many ignore it until it's too late. That's...

Continue Reading
AXIS-Y: Global Expansion Fueled by KRW 430B Valuation

Updated Category News Views 3

Rewriting the Playbook in Global Skincare AXIS-Y decided to do things their way, not just because they could afford to, but because they believed in their vision. Their strategy defies the trends-driven tactics of this cutthroat beauty world. Instead, they’ve been all about climate-inspired products and vegan, cruelty-free standards. And now, after notching up some...

Continue Reading
Nutromics Welcomes Plaxco: Strategic Tech Leap Forward

Updated Category News Views 3

Professor Plaxco’s Dynamic Role at Nutromics Some folks start their day with breakfast and coffee, but Nutromics is grabbing headlines by introducing Professor Kevin Plaxco as the new Chief Scientific Officer. This strategic shift, made public on September 7, 2026, signals Nutromics’ ambition to amplify its DNA-based sensing footprint. As they gear up to launch their...

Continue Reading
Coastal Property Realities: A Deep Dive into Ownership

Updated Category News Views 2

Buying Coastal Property: A Balancing Act Ah, the dream of owning a piece of the beach in sunny South Florida. It sounds glamorous—something to brag about at the next family gathering. But let me tell you, diving into coastal property ownership isn't just about sipping cocktails by the ocean. It's about handling a fair share of headaches most folks don't anticipate....

Continue Reading
NeuralTrust Expands to London as AI Risks Intensify

Updated Category News Views 4

NeuralTrust's Strategic London Expansion In a world where AI agents are sprinting ahead of our security instincts, NeuralTrust makes a big play in the UK market, locking in their position with a new London office. This move isn't just about expansion—it's about tackling the tide of challenges head-on that comes with putting AI agents into the wild. London: A Hub for...

Continue Reading
Early Orders Key for Custom Kids' Gifts This Season

Updated Category News Views 1

Unwrap the Secret to Perfect Holiday Presents When it comes to giving the little ones something special for the holidays, the trick lies in timing. Not your run-of-the-mill timing, mind you—I'm talking about understanding how handcrafted, personalized toys can make or break the season. If you've ever scrambled for a last-minute gift, you know how that shaky feeling sets...

Continue Reading
Stem Cell Market Set for Major Gains to 2031

Updated Category News Views 1

Stem Cells: The Next Frontier or Hype? Folks, stem cells are no longer just a sci-fi concept tucked away in lab coats. This sector's set to boom from USD 18.9 billion in 2026 to a whopping USD 32.57 billion by 2031. Yeah, you heard it right, a solid 11.5% compound annual growth rate. Now, whether you're an investor or just keeping your finger on the biotech pulse, there's...

Continue Reading
Ekinops and 1&1 Versatel Fuel a Connectivity Revolution

Updated Category News Views 1

A European Partnership for Modern Connectivity Big players in the telecom industry are joining forces, and it's like watching a seasoned boxer find his perfect sparring partner. Today, Ekinops, a heavyweight in European connectivity, is shaking hands with 1&1 Versatel, a lead puncher in Germany's B2B communications. They're rolling out a unified connectivity portfolio...

Continue Reading
DoorDash Speeds Up Gifting: Same-Day Delivery Wins

Updated Category News Views 1

Transforming Urgent Gift-Giving with Local Delivery Ever found yourself scrambling for a last-minute gift when time seems to be slipping away? That's where DoorDash steps up, changing the game with their same-day delivery options. In the fast-paced world we're living in, folks aren't just leaning on DoorDash for takeout anymore. They're pushing it as a lifeline for...

Continue Reading

Top 5 Most Recently Viewed Articles

Regeneron Advances Libtayo® for Treating Squamous Cell Carcinoma

Updated Category News Views 218

Regeneron Pharmaceuticals Secures Positive Opinion for Libtayo Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has made a significant stride in oncology with the recent endorsement from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP). They have issued a positive opinion for Libtayo (cemiplimab) as an adjuvant treatment to combat...

Continue Reading
Important Legal Update for Investors in Extreme Networks, Inc.

Updated Category News Views 131

Investor Warning: Key Deadline Approaching for Extreme Networks The Law Offices of Frank R. Cruz have a vital reminder for shareholders of Extreme Networks, Inc. As the deadline to file a lead plaintiff motion approaches, it is crucial that you stay informed about the details surrounding the class action lawsuit concerning the company. Understanding the Class Action This...

Continue Reading
The Rising Wave of Personal Watercraft Market Expansion

Updated Category News Views 79

Understanding the Personal Watercraft Market Surge As the enthusiasm for recreational water sports grows, the personal watercraft market is riding a wave of expansion. Recent projections indicate that the market will ascend from USD 2.7 billion in 2022 to an impressive USD 4.82 billion by 2032, with a robust compound annual growth rate (CAGR) of 6.0% during this period....

Continue Reading
Bybit Rethinks Crypto Security with AI Innovations

Updated Category News Views 185

Bybit Rethinks Crypto Security with AI Innovations Bybit is making impressive advancements in security protocols for its users by utilizing advanced artificial intelligence technologies. As one of the leading cryptocurrency exchanges worldwide, Bybit is dedicated to protecting its users' assets against increasingly sophisticated cyber threats. In a remarkable feat during...

Continue Reading
Exciting Nitro Circus and Dickies Partnership for Families

Updated Category News Views 242

An Exciting Partnership Between Nitro Circus and Genuine Dickies Nitro Circus, a pioneering force in action sports entertainment, has recently announced an innovative partnership with Genuine Dickies, a beloved workwear brand. The culmination of this partnership will be a thrilling 12-stop retailtainment tour taking place at select Walmart locations this summer. This tour...

Continue Reading